mouse ror1 fc (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
mouse ror1 fc
Mouse Ror1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ror1/Recombinant+Mouse+ROR1+Fc+Chimera+Protein%2C+CF/pm41479906-61-9-11
Average 94 stars, based on 4 article reviews
Mouse Ror1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ror1/Recombinant+Mouse+ROR1+Fc+Chimera+Protein%2C+CF/pm41479906-61-9-11
Average 94 stars, based on 4 article reviews
mouse ror1 fc - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies. Article Snippet: Antibodies were captured on FAB2G (AntihIgG CH1 Capture) biosensors (Sartorius) at 5 mg/mL (34 nM). Article Title: Co-opting signalling molecules enables logic-gated control of CAR T cells Article Snippet: A total of 1 × 10 5 CAR + T cells (day 10 after activation) were co-cultured with tumour cells in a 1:1 E:T ratio in complete RPMI medium and incubated at 37 °C for approximately 24 h. For cells stimulated with anti-CD3/anti-CD28 DynaBeads (Gibco), beads were added to cells at a 3:1 bead:cell ratio. Recombinant:Article Title: Co-opting signalling molecules enables logic-gated control of CAR T cells. Article Snippet: Although chimeric antigen receptor (CAR) T cells have altered the treatment landscape for B cell malignancies, the risk of on-target, off-tumour toxicity has hampered their development for solid tumours because most target antigens are shared with normal cells1,2.. Researchers have attempted to apply Boolean-logic gating to CAR T cells to prevent toxicity3–5; however, a truly safe and effective logic-gated CAR has remained elusive6.. Here we describe an approach to CAR engineering in which we replace traditional CD3ζ domains with intracellular proximal T cell signalling molecules. Article Title: A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies Article Snippet: Antibodies were captured on FAB2G (Anti-hIgG CH1 Capture) biosensors (Sartorius) at 5 μg/mL (34 nM). .. Twofold serial dilution of recombinant human ROR1/Fc, human ROR2/Fc, Article Title: Co-opting signalling molecules enables logic-gated control of CAR T cells Article Snippet: .. HER2, B7-H3 and human and mouse ROR1-targeting CARs were detected using human HER2-Fc, B7-H3-Fc and human or Serial Dilution:Article Title: A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies Article Snippet: Antibodies were captured on FAB2G (Anti-hIgG CH1 Capture) biosensors (Sartorius) at 5 μg/mL (34 nM). .. Twofold serial dilution of recombinant human ROR1/Fc, human ROR2/Fc, Incubation:Article Title: Co-opting signalling molecules enables logic-gated control of CAR T cells. Article Snippet: Although chimeric antigen receptor (CAR) T cells have altered the treatment landscape for B cell malignancies, the risk of on-target, off-tumour toxicity has hampered their development for solid tumours because most target antigens are shared with normal cells1,2.. Researchers have attempted to apply Boolean-logic gating to CAR T cells to prevent toxicity3–5; however, a truly safe and effective logic-gated CAR has remained elusive6.. Here we describe an approach to CAR engineering in which we replace traditional CD3ζ domains with intracellular proximal T cell signalling molecules. |
